REBECCA WERNLI: Open Payments
NPI 1689014250 · GREELEY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 14 payments from 11 companies in 2025. Trend: 2023 $3,366 · 2024 $1,212 · 2025 $540
Food & beverage: $445Education: $95
| Company | Payments | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 3 | $204 |
| Actelion Pharmaceuticals US, Inc. | 1 | $95 |
| Medtronic, Inc. | 1 | $81 |
| Amgen Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| CVRx, Inc. | 1 | $20 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
| Organogenesis Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: OPSUMIT, MICRA, REPATHA, CAMZYOS, Barostim Neo System, Assure WCD, LifeVest, PURAPLY WOUND MATRIX.
Industry payments across CO — which companies pay providers there.
